Eli Lilly could launch obesity drug in India next year, CEO saysEli Lilly plans to launch its diabetes and obesity drug, Mounjaro, in India next year. The drug contains tirzepatide and is sold as Zepboun...
Eli Lilly lays off 120 employees in India after Cipla saleThe sales team was informed of the decision at a virtual town hall organised last week in conjunction with the media announcement of the de...
Lupin, Eli Lilly join hands for insulin launchLupin said it will market Eglucent through its own specialty field force while Lilly will be responsible for manufacturing and import.